Ushering in a new era of suture-free tissue reconstruction for better healing
August 1, 2025
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.
EvoEndo announced today that it received expanded FDA clearance for its Model LE gastroscope, covering patients of all ages.
Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.
Current methods for cancer diagnosis are based on identifying biomarkers—molecules that reveal a particular state or process in the body—produced by the tumor or associated proteins. Not surprisingly, these markers are more abundant once the tumor has already developed significantly. And the more advanced the tumor, the more difficult it is to find effective treatment options.
Scientists at UCSF have found that endometriosis—a painful chronic disease affecting 10% of women that often goes undiagnosed—often occurs alongside conditions like cancer, Crohn’s disease, and migraine.
Animals that hibernate are incredibly resilient. They can spend months without food or water, muscles refusing to atrophy, body temperature dropping to near freezing as their metabolism and brain activity slow to a crawl. When they emerge from hibernation, they recover from dangerous health changes similar to those seen in type 2 diabetes, Alzheimer’s disease, and stroke.
To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test captures a person’s average blood glucose levels over the previous few months. But HbA1c cannot predict who is at highest risk of progressing from healthy to prediabetic, or from prediabetic to full-blown diabetes.
SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid arthritis (RA).
AUSTIN, Texas, July 30, 2025 /PRNewswire/ — Alafair Biosciences, a medical device company redefining soft-tissue protection in orthopedic surgery, announced today that it has received two 510(k) clearances from the FDA for VersaCoat™ Tendon Protector and VersaCoat™ Nerve Protector, marketed as a single product, VersaCoat™ Flowable Hydrogel.
Bioventus (Nasdaq:BVS) announced today that it received FDA 510(k) clearance for both its TalisMann and StimTrial offerings.